|
|
|||
|
||||
OverviewThe development of new biomedical technologies has some enthusiastic proponents - scientists, the medical community, patient organisations, and politicians all hope for new cures and new industrial applications. At the same time, there is resistance to the new technologies from other groups for a variety of religious, political, and ethical reasons. In this book, Anders Persson and Stellan Welin address the important perspectives on xenotransplantation and human embryonic stem cell research. For various reasons, the methods have been fervently promoted and equally vehemently opposed by different groupings. The authors investigate the political, social, and ethical forces at work, and discuss how this kind of research and development is affected by the necessary involvement of commercial actors and strong financial incentives. Stories of hope, fear, and hype are matched by stories of success, failure, and fraud. Xenotransplantation and the use of human embryonic stem cells are truly contested technologies. Full Product DetailsAuthor: Anders Persson , Stellan WelinPublisher: Nordic Academic Press Imprint: Nordic Academic Press Dimensions: Width: 14.50cm , Height: 2.00cm , Length: 21.50cm Weight: 0.464kg ISBN: 9789185509058ISBN 10: 9185509051 Pages: 210 Publication Date: 10 December 2008 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationAnders Persson has PhD in sociology from the University of Gothenburg, Sweden. He has a background in sociology of science and science ethics. Stellan Welin is a professor of biotechnology, culture, and society at the University of Linköping, Sweden. He has a PhD in philosophy and has participated in several projects on the ethical issues in emerging biomedical technologies. Tab Content 6Author Website:Countries AvailableAll regions |
||||